These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 1356150

  • 1. Ro 19-8022, a nonbenzodiazepine partial agonist at benzodiazepine receptors: neuropharmacological profile of a potential anxiolytic.
    Jenck F, Moreau JL, Bonetti EP, Martin JR, Haefely WE.
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1121-7. PubMed ID: 1356150
    [Abstract] [Full Text] [Related]

  • 2. 5-ethoxymethyl-7-fluoro-3-oxo-1,2,3,5-tetrahydrobenzo[4,5]imidazo[1,2a]pyridine-4-N-(2-fluorophenyl)carboxamide (RWJ-51204), a new nonbenzodiazepine anxiolytic.
    Dubinsky B, Vaidya AH, Rosenthal DI, Hochman C, Crooke JJ, DeLuca S, DeVine A, Cheo-Isaacs CT, Carter AR, Jordan AD, Reitz AB, Shank RP.
    J Pharmacol Exp Ther; 2002 Nov; 303(2):777-90. PubMed ID: 12388665
    [Abstract] [Full Text] [Related]

  • 3. Relationship between benzodiazepine receptor occupancy and functional effects in vivo of four ligands of differing intrinsic efficacies.
    Facklam M, Schoch P, Bonetti EP, Jenck F, Martin JR, Moreau JL, Haefely WE.
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1113-21. PubMed ID: 1318371
    [Abstract] [Full Text] [Related]

  • 4. TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates.
    Atack JR, Wafford KA, Tye SJ, Cook SM, Sohal B, Pike A, Sur C, Melillo D, Bristow L, Bromidge F, Ragan I, Kerby J, Street L, Carling R, Castro JL, Whiting P, Dawson GR, McKernan RM.
    J Pharmacol Exp Ther; 2006 Jan; 316(1):410-22. PubMed ID: 16183706
    [Abstract] [Full Text] [Related]

  • 5. CGS 9896: agonist-antagonist benzodiazepine receptor activity revealed by anxiolytic, anticonvulsant and muscle relaxation assessment in rodents.
    Bernard PS, Bennett DA, Pastor G, Yokoyama N, Liebman JM.
    J Pharmacol Exp Ther; 1985 Oct; 235(1):98-105. PubMed ID: 2995650
    [Abstract] [Full Text] [Related]

  • 6. Behavioral and biochemical characterization of benzodiazepine receptor partial agonists in pigeons.
    Witkin JM, Acri JB, Wong G, Gleeson S, Barrett JE.
    J Pharmacol Exp Ther; 1996 Apr; 277(1):87-96. PubMed ID: 8613971
    [Abstract] [Full Text] [Related]

  • 7. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
    Depoortere H, Zivkovic B, Lloyd KG, Sanger DJ, Perrault G, Langer SZ, Bartholini G.
    J Pharmacol Exp Ther; 1986 May; 237(2):649-58. PubMed ID: 2871178
    [Abstract] [Full Text] [Related]

  • 8. Anticonvulsant, anxiolytic, and non-sedating actions of imidazenil and other imidazo-benzodiazepine carboxamide derivatives.
    Auta J, Kadriu B, Giusti P, Costa E, Guidotti A.
    Pharmacol Biochem Behav; 2010 Jun; 95(4):383-9. PubMed ID: 20227434
    [Abstract] [Full Text] [Related]

  • 9. Ro 16-6028: a novel anxiolytic acting as a partial agonist at the benzodiazepine receptor.
    Martin JR, Pieri L, Bonetti EP, Schaffner R, Burkard WP, Cumin R, Haefely WE.
    Pharmacopsychiatry; 1988 Nov; 21(6):360-2. PubMed ID: 2907644
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics, anticonvulsant efficacy and adverse effects of the beta-carboline abecarnil, a novel ligand for benzodiazepine receptors, after acute and chronic administration in dogs.
    Löscher W, Hönack D, Scherkl R, Hashem A, Frey HH.
    J Pharmacol Exp Ther; 1990 Nov; 255(2):541-8. PubMed ID: 1978730
    [Abstract] [Full Text] [Related]

  • 11. CGS 20625, a novel pyrazolopyridine anxiolytic.
    Williams M, Bennett DA, Loo PS, Braunwalder AF, Amrick CL, Wilson DE, Thompson TN, Schmutz M, Yokoyoma N, Wasley JW.
    J Pharmacol Exp Ther; 1989 Jan; 248(1):89-96. PubMed ID: 2563294
    [Abstract] [Full Text] [Related]

  • 12. Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX).
    Swedberg MD, Jacobsen P, Honoré T.
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1113-21. PubMed ID: 7562477
    [Abstract] [Full Text] [Related]

  • 13. SL651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptors.
    Griebel G, Perrault G, Simiand J, Cohen C, Granger P, Decobert M, Françon D, Avenet P, Depoortere H, Tan S, Oblin A, Schoemaker H, Evanno Y, Sevrin M, George P, Scatton B.
    J Pharmacol Exp Ther; 2001 Aug; 298(2):753-68. PubMed ID: 11454940
    [Abstract] [Full Text] [Related]

  • 14. The pharmacological properties of the imidazobenzodiazepine, FG 8205, a novel partial agonist at the benzodiazepine receptor.
    Tricklebank MD, Honoré T, Iversen SD, Kemp JA, Knight AR, Marshall GR, Rupniak NM, Singh L, Tye S, Watjen F.
    Br J Pharmacol; 1990 Nov; 101(3):753-61. PubMed ID: 1963808
    [Abstract] [Full Text] [Related]

  • 15. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.
    Decker MW, Brioni JD, Sullivan JP, Buckley MJ, Radek RJ, Raszkiewicz JL, Kang CH, Kim DJ, Giardina WJ, Wasicak JT.
    J Pharmacol Exp Ther; 1994 Jul; 270(1):319-28. PubMed ID: 7913497
    [Abstract] [Full Text] [Related]

  • 16. Tetrazepam: a benzodiazepine which dissociates sedation from other benzodiazepine activities. I. Psychopharmacological profile in rodents.
    Keane PE, Simiand J, Morre M, Biziere K.
    J Pharmacol Exp Ther; 1988 May; 245(2):692-8. PubMed ID: 2896794
    [Abstract] [Full Text] [Related]

  • 17. Neuropsychopharmacological profile in rodents of SR 57746A, a new, potent 5-HT1A receptor agonist.
    Simiand J, Keane PE, Barnouin MC, Keane M, Soubrié P, Le Fur G.
    Fundam Clin Pharmacol; 1993 May; 7(8):413-27. PubMed ID: 7904976
    [Abstract] [Full Text] [Related]

  • 18. Aspects of benzodiazepine receptor structure and function with relevance to drug tolerance and dependence.
    Schoch P, Moreau JL, Martin JR, Haefely WE.
    Biochem Soc Symp; 1993 May; 59():121-34. PubMed ID: 7910739
    [Abstract] [Full Text] [Related]

  • 19. Anticonvulsant and behavioral profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor complex.
    Bristow LJ, Hutson PH, Kulagowski JJ, Leeson PD, Matheson S, Murray F, Rathbone D, Saywell KL, Thorn L, Watt AP, Tricklebank MD.
    J Pharmacol Exp Ther; 1996 Nov; 279(2):492-501. PubMed ID: 8930150
    [Abstract] [Full Text] [Related]

  • 20. Anticonvulsant efficacy of the low-affinity partial benzodiazepine receptor agonist ELB 138 in a dog seizure model and in epileptic dogs with spontaneously recurrent seizures.
    Löscher W, Potschka H, Rieck S, Tipold A, Rundfeldt C.
    Epilepsia; 2004 Oct; 45(10):1228-39. PubMed ID: 15461677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.